24-7 Press Release — Industry: Biotechnology Press Releases — RSS Feed & Live Monitoring
PPN World indexes 24-7 Press Release — Industry: Biotechnology press releases and archives each one it distributes. This wire has been quiet since July 1, 2026 — its 29 indexed releases remain searchable, and an alert will tell you the moment it publishes again.
24-7 Press Release — Industry: Biotechnology RSS feed URL
https://rss.24-7pressrelease.com/rss/industry_biotechnology.xmlAbout this feed
24-7 Press Release — Industry: Biotechnology is one of the 900+ press-release feeds PPN World monitors around the clock — an English-language wire focused on Biotech, filed under United States in our country index. Every release is deduplicated, geotagged, and enriched with an AI summary, and you can attach saved-search alerts to any keyword it publishes. The most recent release in our index was published on July 1, 2026; the wire has been quiet since.
How to follow 24-7 Press Release — Industry: Biotechnology press releases
- Copy the 24-7 Press Release — Industry: Biotechnology RSS feed URL shown above.
- Paste it into any RSS reader (Feedly, Inoreader, NetNewsWire…) to get the raw feed.
- Or track 24-7 Press Release — Industry: Biotechnology in PPN World to add deduplication, saved-search alerts, and AI summaries across all 900+ wires.
24-7 Press Release — Industry: Biotechnology press releases — archive
- Next-Generation Precision Obesity Models: Closing the Translational Gap in Anti-Obesity Drug Development11 d ago
Moving Beyond the Scale—How Precision-Engineered Models Are Redefining Preclinical Obesity Research
- Alfa Chemistry Advances Colloidal Stability Engineering for High-Performance Nanodispersion Systems12 d ago
Integrated Colloidal Materials and Application Solutions Help Researchers Optimize Particle Stability Across Semiconductor, Catalysis, and Functional Materials Workflows
- Ace Therapeutics Announces Comprehensive Preclinical Analgesic Drug Development Services with Full-Spectrum Pain Research Platform12 d ago
Ace Therapeutics announces its robust end-to-end solutions dedicated to advancing pain therapeutic development, featuring diverse validated in vivo pain models for drug testing.
- Creative Biolabs: Custom Oligosaccharide Synthesis and Glycan Characterization for Drug Discovery12 d ago
Creative Biolabs has expanded its custom oligosaccharide synthesis and glycan characterization services to help researchers overcome challenges in glycan synthesis, purification, structural analysis,…
- Creative Diagnostics Launches Hantavirus Research Reagents and Products to Accelerate Global Diagnostic and Vaccine Research16 d ago
Creative Diagnostics announces Hantavirus Research Reagents and Products to support hantavirus research and diagnostic assay development.
- Ace Therapeutics Launches Full-Scale Preclinical Hematology CRO Services with Expanded In Vivo Hematologic Disease Models16 d ago
Ace Therapeutics announces its comprehensive suite of integrated preclinical hematology CRO services designed to accelerate the discovery and regulatory advancement of novel therapeutics for a broad s…
- Creative Biolabs Supports Neurodegeneration Research with Advanced iPSC Models18 d ago
Creative Biolabs helps researchers address key challenges in neurodegenerative disease research through iPSC-derived neuronal differentiation services and disease-specific cell models.
- Creative Biolabs Launches End-to-End ASO Development Services23 d ago
To address stability and targeted delivery challenges in RNA therapeutics, Creative Biolabs introduces its comprehensive, one-stop antisense oligonucleotide (ASO) development platform, streamlining wo…
- Creative Biolabs Accelerates Metabolic Disease Drug Discovery with Deep Learning for Multi-Receptor Agonist Design24 d ago
Creative Biolabs has upgraded its AI-driven functional protein solutions, empowering industrial biotechnology clients to rapidly screen millions of peptide sequences.
- Daniel Yansura Presented with the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who's Who33 d ago
Daniel Yansura has been endorsed by Marquis Who's Who as a leader in molecular biology and research
- NEW HORIZON MEDICAL SOLUTIONS PROMOTES RAYMOND JESSEN, MPH, MHSA, CTBS TO SENIOR VICE PRESIDENT OF COMPLIANCE, REGULATORY AFFAIRS & QUALITY40 d ago
Seasoned Regulatory and Compliance Leader Elevated to Strengthen Quality Infrastructure Across NHMS's Medical Device and Regenerative Medicine Portfolio
- Creative Biolabs Advances Anti‑Glycan Antibody Discovery for Glycan‑Shielded Viruses44 d ago
Creative Biolabs addresses major challenges in glycan-shielded virus research with advanced anti-glycan antibody development services for Ebola, Marburg, flavivirus, and other emerging pathogens.
The newest releases on this wire stream live for PPN World members.